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Ellagic and Tannic Acids Protect Newly Synthesized
Elastic Fibers from Premature Enzymatic Degradation
in Dermal Fibroblast Cultures
Felipe Jimenez1, Thomas F. Mitts1,2, Kela Liu3, Yanting Wang3 and Aleksander Hinek1,3,4
Progressive proteolytic degradation of cutaneous elastic fibers, that cannot be adequately replaced or repaired
by adult dermal fibroblasts, constitutes a major feature of aging skin. Our present investigations, employing
monolayer cultures of human dermal fibroblasts and organ cultures of skin biopsies, were aimed at testing
whether the hydrophilic tannic acid (TA) and lipophilic ellagic acid (EA) would protect dermal elastin from
exogenous and endogenous enzymatic degradation. Results from both culture systems indicated that dermal
fibroblasts, maintained with TA or EA, deposit significantly more elastic fibers than untreated control cultures
despite the fact that neither polyphenol enhanced transcription of elastin mRNA or cellular proliferation.
Results of a pulse and chase experiment showed that pretreatment with both polyphenols enhanced
biostability of tropoelastin and newly deposited elastin. Results of in vitro assays indicated that both
polyphenols bound to purified elastin and significantly decreased its proteolytic degradation by elastolytic
enzymes belonging to the serine proteinase, cysteine proteinase, and metallo-proteinase families. Importantly,
both polyphenols also synergistically enhanced elastogenesis induced by selected elastogenic compounds in
cultures of dermal fibroblasts. We propose that EA and TA may be useful for preventing proteolytic degradation
of existing dermal elastic fibers and for enhancing more efficient elastogenesis in aged skin.
Journal of Investigative Dermatology (2006) 126, 1272–1280. doi:10.1038/sj.jid.5700285; published online 6 April 2006
INTRODUCTION
Children with inherited diseases, characterized by impaired
primary deposition of elastic fibers (i.e. Costello Syndrome
or Cutis Laxa), develop wrinkles and deep dermal creases.
Similar, but steadily developing signs of premature skin
aging can also be observed in individuals with pseudox-
anthoma elasticum and in normal persons after prolonged
exposure to sun. Histological analysis of wrinkled
skin demonstrates disappearance and altered organization
of elastic fibers due to premature proteolytic degradation
and impaired remodeling (solar elastosis) of these
components of dermal extracellular matrix. This observed
loss of physiologically relevant elastic fibers is also affected
by the fact that fully differentiated (adult) dermal fibroblasts
lose their ability to synthesize elastin and thus cannot
replace damaged elastic fibers. As elastic fibers are solely
responsible for cutaneous elasticity/resilience, there is an
obvious need for development of methods that might
protect existing elastic fibers from premature degradation
by elastolytic proteinases and facilitate new elastogenesis
in skin.
We have recently described that a proteolytic digest of
elastin (ProK-60) (Hinek et al., 2005) and trivalent iron (ferric
ammonium citrate) (Bunda et al., 2005) can stimulate
production of new tropoelastin and its effective assembly
into new elastic fibers in primary cultures of human dermal
fibroblasts and in organ cultures of skin explants obtained
from adult individuals. We have also established that even in
optimal conditions the elastogenic process is not 100%
efficient. Therefore, a significant fraction (30–40%) of newly
produced tropoelastin is not assembled into extracellular
elastic fibers and instead interact with the cell surface elastin
receptor (Hinek, 1996) to further enhance new elastogenesis,
stimulate promitogenic and promigratory signaling pathways
(Mochizuki et al., 2002), and stimulate secretion of elastolytic
metalloproteinases (Brassart et al., 2001; Huet et al., 2001).
Whereas stimulation of dermal fibroblast proliferation and
migration can contribute to an overall antiaging effect,
induced by factors initially triggering new elastogenesis, the
simultaneous upregulation of elastolytic enzymes may cause
rapid degradation of newly produced elastin and existing
elastic fibers. Hence there is a need to protect existing and
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new elastic fibers from premature enzymatic proteolysis in
order to achieve a ‘‘true’’ antiaging effect.
Ellagic acid (EA) and tannic acid (TA) are polyphenols
found in a wide variety of fruits and nuts such as raspberries,
strawberries, walnuts, grapes, and black currants (de Ancos
et al., 2000; Priyadarsini et al., 2002). These molecules
possess potent ability to scavenge reactive oxygen species
and reactive nitrogen species (Priyadarsini et al., 2002;
Ignatowicz et al., 2003). Recently, EA was shown to decrease
expression of prometalloproteinase (MMP)-2 and pro-MMP-9,
precursors of two elastolytic enzymes (Losso et al., 2004).
Moreover, TA has been shown to bind to insoluble bovine
and porcine elastin and inhibit their degradation by porcine
pancreatic elastase (Isenburg et al., 2004). In this report, we
present novel data indicating that treatment of cultured
human dermal fibroblasts and organ cultures of human skin
biopsies with EA or TA significantly enhances their net
deposition of elastic fibers. We provide evidence that this
effect is due to the fact that these reagents prevent premature
proteolytic degradation of tropoelastin and fully polymerized
elastin (major component of mature elastic fibers) thus
facilitating more efficient elastogenesis.
RESULTS
EA and TA enhance deposition of elastin by dermal fibroblasts
Results of immunohistochemical analysis (Figure 1a and b)
and quantitative assessment of metabolically labeled inso-
luble elastin (Figure 1c) indicated that 7-day-old monolayer
cultures of dermal fibroblasts maintained with EA or TA
contain thicker elastic fibers and a higher net content of
NaOH-insoluble elastin than untreated control cultures.
Moreover, results of morphometric analysis demonstrated
that both EA and TA caused a significant (Po0.005) increase
(6776 and 96712%, respectively) in net elastogenesis
observed in organ cultures of human skin explants main-
tained for 10 days with 5% fetal bovine serum (FBS). The
representative micrographs presented in Figure 2 additionally
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Figure 1. Assessment of immunodetected and insoluble elastic fibers in
dermal fibroblast cultures. (a) Micrographs of immunodetected tropoelastin
in cultures maintained in the presence and absence of EA and TA (1 mg/ml
each). (b) Results of morphometric evaluation of tropoelastin levels in
fibroblast cultures. (c) Evaluation of metabolically labeled insoluble elastin in
treated and control cultures. All results were obtained in 7-day-old cultures of
dermal fibroblasts derived from a 36-year-old Caucasian female. Data
demonstrate that treatment with EA or TA significantly increases deposition of
extracellular elastic fibers as compared to respective untreated controls.
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Figure 2. Movat pentachrome-stained transverse sections of skin biopsy
explants derived from abdominal skin of a 30-year-old woman. The
presented micrographs show that skin explants maintained for 10 days in
culture medium with TA (c) contain thicker and longer elastic fibers than
those present in respective explants treated either with control medium
(a) or with medium containing ProK-60 (b). Panel (d) shows that TA also
significantly enhanced the elastogenic effect of ProK-60. Movat’s
pentachrome stain shows elastin as black, collagen as yellow, cells red,
and nuclei as dark blue (original magnification 200).
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demonstrate that explants maintained for 10 days in culture
media containing TA (Figure 2c) contain thicker and longer
elastic fibers than those present in explants maintained only
in control medium (Figure 2a) or medium with ProK-60
(Figure 2b). Interestingly, the presence of TA seems to
particularly enhance elastogenesis in cells protruding from
the stratum basale, toward the papillary dermis, and in cells
surrounding small capillaries. Results of semiquantitative
PCR and Northern blotting indicated, however, that treatment
of cultured dermal fibroblasts with EA or TA did not induce
any increase in the transcription of their elastin gene (data not
shown) nor change their proliferation rate, as assessed by
incorporation of radioactive thymidine and total DNA
content (data not shown). Despite this finding, results of
Western blotting, with anti-tropoelastin antibody, showed
that both cell extracts and conditioned media, of dermal
fibroblasts incubated with EA or TA, contained more intact
70 kDa tropoelastin and less immuno-detectable degradation
products of lower molecular weight than untreated counter-
parts (Figure 3). This finding gave evidence that both
polyphenols protected newly produced tropoelastin from
premature intracellular and pericellular degradation by
endogenous proteinases.
EA and TA protect elastin from proteolytic degradation
Results of a pulse and chase experiment (Figure 4a and b)
demonstrated that cultures of dermal fibroblasts, exposed for
7 days to EA and TA, sustain their high net content of
insoluble elastin (metabolically pulsed with [3H]valine
between days 4 and 7) when maintained for an additional
7 days (chase period) in media containing only 1% FBS (no
EA or TA), which did not stimulate proliferation (Figure 4c)
and new elastogenesis. In contrast, 14-day-old control
(untreated) cultures demonstrated a significant decrease in
their net content of metabolically labeled insoluble elastin
(detected at the end of pulse period, at day 7). Moreover,
results of an in vitro elastolytic assay demonstrated that
samples of purified insoluble elastin (purity confirmed by
amino-acid analysis), pretreated with EA or TA, were more
resistant to proteolytic degradation by all tested elastolytic
enzymes belonging to the serine proteinase (human leuko-
cyte elastase and porcine pancreatic elastase), MMP-2, and
cysteine proteinase (papaine) families (Figure 5). These data
suggested that EA and TA protected newly deposited and
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Figure 3. Representative Western blot of tropoelastin in cell extracts and
media. Western blotting with anti-tropoelastin antibody demonstrates that
both cell extracts and conditioned media, of dermal fibroblasts incubated for
24 hours with EA or TA (1 mg/ml each), contain more intact 70 kDa
tropoelastin and less immunodetectable degradation products of lower
molecular weight than untreated counterparts. The results depicted represent
a single experiment, but identical beneficial influence of TA and EA on the
integrity of intracellular and secreted tropoelastin has been confirmed in
triplicate cultures of fibroblasts derived from three different donors.
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Figure 4. Pulse and chase experiment to evaluate pretreated tropoelastin/
elastin stability against nonspecific enzymatic degradation. (a) Results of
morphometric assessment of immunodetectable elastin and (b) content of
metabolically labeled insoluble elastin, detected at the respective ends of the
indicated pulse and chase periods, demonstrate that cultures of dermal
fibroblasts derived from a 26-year-old female, while were incubated the first
7 days in the presence of EA and TA (1 mg/ml each), sustain their high net
content of insoluble elastin (metabolically pulsed with [3H]valine between
days 4 and 7) even when maintained for an additional 7 days (chase period) in
media containing only 1% FBS and no polyphenols. In contrast, 14-day-old
control (untreated) cultures demonstrate a significant decrease in their net
content of metabolically labeled insoluble elastin (initially deposited at the
end of pulse period, at day 7). (c) The assessment of [3H]thymidine
incorporation and assay of total DNA indicate that conditions of the chase
period in which cells were maintained in 1% FBS caused inhibition of cellular
proliferation.
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purified insoluble elastin against degradation by both endo-
genous and exogenous elastolytic enzymes, respectively,
through association with elastin.
EA and TA bind to elastin and tropoelastin
Results of a spectrophotometric assay (displaying a linear
concentration curve for both EA and TA at an absorbance of
280 nm), comparing concentrations of both polyphenols
before and after incubation with insoluble elastin, demon-
strated that 1 mg of pure insoluble elastin, isolated from
ligamentum nuchae, absorbed 8773% of the TA, and
8172% of the EA in solutions having had initial concentra-
tions of 20 mg/ml of each polyphenol. This finding implied
that both polyphenols bind to insoluble elastin. Additional
results showed that preincubation of a [3H]valine-labeled
recombinant peptide, containing the most characteristic hydro-
phobic and crosslink generating domains of tropoelastin, with
EA and TA did not preclude its effective (practically identical)
immunoprecipitation with respective anti-VGVAPG and
anti-AKAAAKAAAKA antibodies (data not shown). This
indicated that these polyphenols associate with and protect
tropoelastin in a way which does not obscure hydrophobic
domains (e.g. VGVAPG), necessary for self-aggregation, nor
KAAAK sequences participating in crosslinking.
EA and TA enhance elastogenic effect of selected stimulators of
elastogenesis
Results of immunostaining and metabolic labeling estab-
lished that addition of EA or TA to fibroblast cultures
simultaneously treated with known stimulators of elastin
gene expression, ProK-60 (Hinek et al., 2005) or ferric
ammonium chloride (Bunda et al., 2005), significantly
enhanced their net deposition of insoluble elastin as
estimated in 7-day-old monolayer cultures (Figure 6). Mor-
phometric analysis additionally demonstrated that both
polyphenols significantly (Po0.02) enhanced elastogenic
effect of ProK-60 observed in 10-day-old organ cultures
of human skin explants (EA¼2274 and TA¼3576%).
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Figure 5. Evaluation of the protective effect of polyphenols against
elastolytic degradation of insoluble elastin. Results of in vitro assay
demonstrate that samples of insoluble [3H]elastin from bovine ligamentum
nuchae, pretreated with EA or TA (1 and 10 mg/ml each), demonstrate higher
resistance to proteolytic degradation by indicated enzymes belonging to three
different classes of proteinases (elastases) capable of elastin degradation.
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Figure 6. Assessment of the effect of polyphenols on elastogenesis induced
by known elastogenic compounds. (a) Results of the quantitative assessment
of newly deposited insoluble elastin (metabolically labeled with [3H]valine)
detected in 7-day-old cultures of dermal fibroblasts derived from a healthy
50-year-old Caucasian female. Fibroblasts maintained in the presence of
stimulators of elastin synthesis, mixture of small elastin-derived peptides
(ProK-60, 25 mg/ml) or ferric ammonium citrate (FAC, 20 mM), significantly
increased their net deposition of insoluble elastin as compared with the
untreated control. Additional treatment either with EA (1 mg/ml) or TA (1 mg/
ml) caused further proportional increase in net elastin content in all tested
experimental groups. (b) Representative micrographs of 7-day-old cultures of
dermal fibroblasts (derived from 50-year-old Caucasian female) immunos-
tained with anti-tropoelastin antibody. Cultures treated with ProK-60 (25 mg/
ml) produced more elastic fibers than untreated control cultures. Additional
treatment either EA or with TA (both in 1 mg/ml concentration) caused a
further increase in net deposition of immunodetectable elastic fibers.
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Representative micrographs depicting synergistic effect of
ProK-60 and TA are presented in Figure 2d.
DISCUSSION
Our results demonstrate that the two polyphenols, EA and TA,
used in concentration of 1 mg/ml, did not modulate cellular
proliferation of normal human dermal fibroblasts, despite the
fact that antiproliferative properties of both of these com-
pounds were reported in cultures of various normal and
malignant cell lines when used in higher doses (Ramanathan
et al., 1992; Devi and Das, 1993; Losso et al., 2004). Dermal
fibroblasts treated with both acids did not demonstrate any
increase in levels of elastin mRNA yet facilitated a significant
increase in net elastic fiber content detected by immuno-
chemistry and metabolic labeling of insoluble elastin. We
therefore speculated that both EA and TA might bind to
intracellular tropoelastin and to newly assembled crosslinked
elastin and protect them from proteolytic degradation by
fibroblast-secreted proteolytic enzymes engaged in early
remodeling of extacellular matrix. Our hypothesis regarding
potential preferential binding of both polyphenols to intra-
cellular tropoelastin and extracellular elastin polymer was
based on a previously described observation that addition of
0.25% TA to glutaraldehyde fixative dramatically enhanced
contrast of intracellular secretory vesicles containing tropo-
elastin and contrast of extracellular elastic fibers in tissues
observed under the electron microscope (Hinek et al., 1976;
Hinek and Thyberg, 1977, 1981). In fact, in the preimmuno-
staining era, treatment with TA became a widely accepted
method for ultrastructural identification of elastic fibers that
were previously described as ‘‘electron lucent and amor-
phous’’ under electron microscopy (Kageyama et al., 1985).
This hypothesis was further supported by results of our pulse-
and-chase experiment where EA and TA pretreated tropo-
elastin and insoluble elastin, deposited by dermal fibroblasts,
remained resistant against nonspecific endogenous degrada-
tion in the absence of EA or TA in culture medium. We also
showed that preincubation of 3H-labeled pure insoluble
elastin, with either EA or TA, significantly reduced its rate of
degradation (in the absence of either polyphenol in the digest
buffer) by several exogenous elastolytic enzymes including
porcine pancreatic elastase, human leukocyte elastase,
papaine, and the UVB-inducible MMP-2. Results of this
protection assay are consistent with recent observations of
Isenburg et al. (2004, 2005), who described that addition of
TA to the glutaraldehyde fixation process increased the
stability of porcine aortic explants exposed to pancreatic
elastase digestion. Moreover, our spectrophotometric study
demonstrated that pure insoluble elastin, isolated from
ligamentum nuchae, binds both TA and EA, sequestering
them from their solvent solutions. Results of this study are in
further agreement with those of Isenburg et al. (2004) who
demonstrated similar binding of TA by pure aortic elastin
over time.
Our studies did not estimate how much of the described
protective effect of EA and TA could also be due to direct
inhibition of elastolytic proteinases. It has previously been
shown that plant-derived polyphenols, tannins, and their
synthetic derivatives can inhibit human leukocyte elastase
(Mrowietz et al., 1991) and MMP-2/-9 activity in several
tumor cells (Vayalil et al., 2004; Tanimura et al., 2005).
Other studies directly demonstrated that TA specifically
inhibits the chymotrypsin-like activity of purified 20S
proteasomes (Nam et al., 2001) and the activity of tissue-
type plasminogen activator, urokinase-type plasminogen
activator, and plasmin activity (Taitzoglou et al., 2000,
2001). We therefore, speculate that a certain fraction of the
described protective effect may be due to a direct inhibition
of proteolytic enzymes by both polyphenols absorbed by or
released from the elastin substrate.
The practical biological significance of our observation is
that EA or TA added to cultures of living cells facilitate
normal secretion of tropoelastin and its assembly into elastic
fibers by protecting intra- and extracellular tropoelastin from
degradation by unspecific proteinases. As EA and TA did not
block domains responsible for self-aggregation and subse-
quent crosslinking of this protein, we speculate that EA and
TA may act in concert with the 67-kDa elastin binding
protein that acts as a protective molecular chaperone for
intracellular tropoelastin. Moreover, the fact that EA and TA
significantly decreased degradation of newly produced
elastin, in dermal fibroblast cultures, and fully crosslinked
elastin, from ligamentum nuchae, indicates that both poly-
phenols may enhance longevity of elastic fibers.
Given the presented beneficial effects of both tested
polyphenols, we hypothesize that both may be used in
topical preparations aimed at prevention of elastin degrada-
tion characteristic of normal aging and after chronic exposure
to sunlight (photoaging). As EA and TA did not negatively
interfere with the action of two known stimulators of new
elastogenesis, but rather enhanced their net effect, we further
propose their use in combination with compounds aimed at
restoring cutaneous elastic fibers, not only in aged skin, but
also in the skin of patients afflicted by diseases caused by
elastin gene insufficiency (i.e. Williams–Beuren syndrome and
Cutis Laxa). Results of our recent experiments (data not shown)
indicated that TA and EA prevented rapid, MMP-dependent
degradation of tropoelastin produced by dermal fibroblasts
derived from three Williams–Beuren syndrome patients,
yielding a significant (21–26%) net increase in deposition of
insoluble elastin by these cells. However, further in vivo
studies must be undertaken to determine if topical treatment
with EA or TA will result in deposition of functionally
competent elastic fibers that will lead to enhanced elasticity
and aesthetic qualities of aged and diseased skin. Being aware
of studies showing that higher dosages (200–300mg) of EA
initiated blood coagulation (Bock et al., 1981; Chino et al.,
2003) and thrombosis in experimental animals after its intra-
arterial injection (Uzunova et al., 1978; Hara et al., 1994), we
conclude that of the two tested polyphenols, TA is the more
promising therapeutic reagent for future translational studies.
Thus, results of our in vitro studies, presented herein, and lack
of previously described clinical side effects of TA fully
encourage its use in clinical studies aimed at demonstrating
in vivo protection of existing elastic fibers and more efficient
elastogenesis in skin.
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MATERIALS AND METHODS
Materials
All chemical-grade reagents were obtained from Sigma (St Louis,
MO). aMEM medium, FBS, 0.2% trypsin–0.02% EDTA, and other
cell culture products were obtained from GIBCO Life Technologies
(Burlington, Canada). Polyclonal antibody to tropoelastin and BA4
mAb to VGVAPG were purchased from Elastin Products Company
Inc. (Owensville, MO). Monospecific polyclonal anti-AKAAAKAAA-
KA antibody was a generous gift of Dr Barry Starcher from the
University of Texas. Secondary antibody fluorescein-conjugated goat
anti-rabbit (GAR-FITC) was purchased from Sigma (St Louis, MO).
DNeasy Tissue system for DNA assay and RNeasy Mini Kit for
isolation of total RNA were purchased from Qiagen (Mississauga,
Canada). Expression probe for elastin was purchased from Applied
Biosystems (Foster City, CA, USA). The radiolabeled reagents,
[3H]valine, and [3H]thymidine were purchased from Amersham
Canada Ltd (Oakville, Canada).
Cell cultures
Biological effects of EA and TA were tested in cultures of dermal
fibroblasts derived from punch biopsies of healthy skin from
Caucasian female subjects of different ages ranging from 4 to 52
years old. All fibroblasts were originally isolated by allowing them to
migrate out of skin explants and then passaged by trypsinization and
maintained in alpha-minimum essential medium supplemented with
20 mM 4-(2-hydroxyethyl)-1-piperazineethane sulphonic acid
(HEPES), 1% antibiotics and antimycotics, 1% L-glutamate, and 2%
FBS as previously described (Hinek et al., 2000b). In all experiments,
consecutive passages 3–5 were tested. Cells were densely plated
(50 105 cells/dish) to reach confluency and then cultured for 7 days
in the presence and absence of EA (dissolved in DMSO) and TA
(dissolved in water), both in concentration of 1mg/ml. This optimal
concentration was chosen after a series of pilot experiments
indicated that 1mg/ml of EA and TA induced optimal effect on net
deposition of elastin and did not trigger any change in cellular
proliferation rate nor affect basic metabolic performance.
In a parallel series of experiments, cultures of dermal fibroblasts
were treated with well-established stimulators of tropoelastin
synthesis, ProK-60 (25 mg/ml) (Hinek et al., 2005) and ferric
ammonium citrate (20 mM) (Bunda et al., 2005), and simultenously
incubated in the presence and absence of EA or TA (both in
concentration 1 mg/ml).
Institutional Review Board approval and patient informed
consent were obtained for this study. Guidelines for the protection
of human subjects of the Department of Health and Human Services
and of the Declaration of Helsinki Principles were strictly followed
in obtaining tissues for this investigation.
Assessment of cellular proliferation
Cellular proliferation rates of control and EA- and TA-treated
fibroblasts were assessed at the end point by counting of trypsinized
cells, by total DNA assay using the DNeasy Tissue System from
Qiagen and by assessment of [3H]thymidine incorporation, which
was added to all cultures (2mCi/well) for the last 24 hours as
described previously (Hinek and Wilson, 2000; Hinek et al., 2000a).
Assessment of elastin mRNA levels
Fibroblasts were cultured to confluency in medium with 2% FBS and
then in serum-free medium for 24 hours. The medium was changed
again and cells were incubated for the next 24 hours in the presence
and absence of EA or TA (both in 1mg/ml concentration). At the end
of the incubation period, total RNA was extracted using TRIs
Reagent (Sigma, St Louis, MO). Steady-state levels of elastin mRNA
were analyzed by semiquantitative PCR and by Northern blot using a
human elastin cDNA recombinant H-11 probe, as described
previously (Urban et al., 2002). In all experiments, performed in
triplicate, the loading control was routinely performed.
Assessment of elastic fiber content by immunohistochemistry
Cultures of fibroblasts, 7- and 14-day-old, which produce abundant
extracellular matrix, were assessed. All cultures were fixed in cold
100% methanol at 201C for 30 min, and then incubated for 1 hour
with 2 mg/ml of polyclonal antibody to tropoelastin. Cultures were
then incubated for an additional hour with appropriate fluorescein-
conjugated secondary antibody (GAR-FITC). Nuclei were counter-
stained with propidium iodide (Hinek et al., 2000a). Morphometric
analysis of five separate cultures in each experimental group,
immunostained with antibodies recognizing extracellular matrix
components, was performed using a computerized video analysis
system (Image-Pro Plus software 3.0, Media Cybernetics, Silver
Spring, MD) as described previously (Hinek and Wilson, 2000;
Hinek et al., 2000a).
Radioactive metabolic labeling and quantification of newly
deposited insoluble elastin
Quintuplicate, 4-day-old cultures of dermal fibroblasts maintained in
the presence and absence of 1mg/ml of EA or TA were additionally
exposed for the 3 following days to 20 mCi [3H]valine. At the end of
the incubation period, the contents of radioactive, NaOH-insoluble,
elastin was assessed separately in each culture by scintillation
counting, as described previously (Hinek and Wilson, 2000; Hinek
et al., 2000a). Final results reflecting amounts of metabolically
labeled, insoluble elastin were expressed as c.p.m./mg DNA. DNA
was determined with the DNeasy Tissue System from Qiagen.
Pulse and chase experiments aimed at the assessment of
durability of newly deposited metabolically labeled elastin
In this series of experiments, dermal fibroblasts, plated as described
above in media with 10% FBS, were maintained in the presence and
absence of 1mg/ml of EA or TA for the first 7 days and pulsed with
20 mCi [3H]valine between days 4 and 7. Whereas quadruplicate
7-day-old cultures from each experimental group were directly
processed for the assessment of radioactive NaOH-insoluble elastin,
parallel quadruplicate cultures from each experimental group were
transferred to media containing only 1% FBS, which did not
stimulate proliferation and new elastogenesis, and maintained for
the next 7 days (chase period) in the absence of EA or TA. At day 14,
these cultures were terminated and the net content of the radioactive
NaOH-insoluble elastin was assessed as described above.
Organ cultures of explants derived from surgical biopsies of
human skin
In order to further test whether EA and TA would penetrate into skin
tissue and enhance elastogenesis, fragments of normal skin (from
30- and 34-year-old women) obtained during plastic surgery
procedures were tested in organ culture system. Informed patient
consent and local Institutional Review Board approval were
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obtained and guidelines of the Declaration of Helsinki Principles for
the protection of human subjects were strictly followed in collecting
excess skin fragments. Skin fragments were cut into multiple 1 mm2
pieces and placed on top of metal grids immersed in culture medium
containing 5% FBS and maintained for 10 days in the presence and
absence of 1mg/ml of EA or TA alone or combined with 25 mg/ml of
ProK-60. The media were changed every second day. All organ
cultures were fixed in 1% buffered formalin and their transversal
serial histological sections were stained with Movat’s pentachrome
as described previously (Hinek et al., 2005). Morphometric analysis
was performed as described above. In each analyzed group (three
explants from each patient), low-power fields (1 mm2) of 20 serial
sections stained with Movat’s pentachrome were analyzed and all
structures stained black (elastic fibers) were counted.
Assessement of tropoelastin integrity by Western blots
To determine the influence of TA and EA on the integrity of soluble
tropoelastin, dermal fibroblasts obtained from three different donors
(initially plated at 50,000 cells/dish) were cultured to confluency in
medium with 5% FBS and then triplicate cultures were incubated
for the next 24 hours in the presence and absence of EA or TA (both
in 1mg/ml concentration). At the end of the incubation period,
conditioned media were collected and then the soluble proteins
present in the intracellular compartments were extracted with
0.5 M acetic acid in the presence of proteinase inhibitors in the
following final concentrations: 2 mM benzamidine, 2 mM E-amino-
caproic acid, 2 mM phenylmethylsulfonyl fiuoride, 1 mM EDTA,
and 1 mg/ml Trasylol, as previously described (Hinek and Rabino-
vitch, 1994). Extraction was carried out for 6 hours at 41C and the
insoluble material was pelleted by centrifugation. The supernatant
was dialyzed exhaustively (4,000 kDa cutoff membrane) at 41C
against water containing proteinase inhibitors, then lyophilized.
Concentrated preparations of the conditioned media and cell
extracts from all analyzed cultures were analyzed for their protein
content, and then samples containing equal amounts of protein
(20 mg/sample) were suspended in 2 SDS sample buffer with
dithiothreitol, resolved by SDS-PAGE, routinely transferred to
nitrocellulose and immunoblotted with specific anti-tropoelastin
antibody.
Immunoprecipitation of radioactive tropoelastin-like peptides
This experiment was aimed at elucidating whether binding of EA or
TA to tropoelastin molecules would block two characteristic elastin
domains responsible for orderly self-aggregation and crosslinking,
respectively. Instead of very unstable tropoelastin, we used triplicate
samples of a [3H]valine-labeled recombinant polypeptide containing
linear amino-acid sequences encoded by human tropoelastin gene
exons 20-(21-23-24)2 (generous gift of Dr Fred Keeley from the
Hospital for Sick Children in Toronto) that have been proven as a
convenient tool for studies of tropoelastin self-aggregation and
crosslinking (Miao et al., 2003). Samples (100 ml) of this radioactive
recombinant polypeptide modeled after human elastin dissolved in
PBS (specific radioactivity 1,000 c.p.m./sample) were incubated in
the presence and absence of 1 mg/ml of EA or TA, at room tempe-
rature for 6 hours. Aliquots of all control and experimental samples
were then immunoprecipitated with (BA4) mAb (recognizing
VGVAPG and other similar domains, encoded by exons 20 and
24, responsible for self-aggregation of tropoelastin) and with
monospecific polyclonal anti-AKAAAKAAAKA antibody recognizing
the exon 21- and 23-encoded crosslinking sequences (Starcher et al.,
1999). We anticipated that in case that binding of EA or TA would
block one or both of these crucial domains present in the tested
radioactive recombinant peptide, it could not be immunoprecipi-
tated with anti-VGVAPG or anti-AKAAAKAAAKA antibodies.
Proteolytic degradation protection assay of insoluble elastin
To determine whether EA or TA may directly protect fully
crosslinked ‘‘insoluble elastin’’ against elastolytic activity of several
elastases, an in vitro assay measuring degradation of an insoluble
[3H]elastin substrate was used as described previously (Hinek and
Rabinovitch, 1994). Briefly, insoluble elastin was purified from
bovine ligamentum nuchae using a modification of the hot alkali
technique as previously described (Mecham et al., 1997) and was
shown by amino-acid analysis to be free of microfibrillar protein and
other contaminants. Sequencing of insoluble, digested elastin was
performed using an Applied Biosystems model 473A protein
sequencer equipped with a model 610A data analysis program.
The stock of this pure insoluble elastin preparation was washed
twice with water and twice with acetonitrile and then labeled with
sodium [3H]borohydride as previously described (Banda and Werb,
1981) and stored at 201C. Before each experiment, the [3H]elastin
substrate suspended in PBS was boiled for 5 minutes and extensively
washed to remove all unbound radioactivity. Then, its 100 mg
aliquots (specific activity 300 c.p.m./1 mg) were suspended in serum-
free culture medium and preincubated for 1 hour in the presence and
absence of 1 or 10 mg/ml of EA or TA. All samples of radioactive
elastin were then submitted to three 5 minutes washes in serum-free
culture medium before their 18 hours incubation at 371C with
aliquots (50 ng) of human leukocyte elastase, porcine pancreatic
elastase, MMP-2, or papaine dissolved in the assay buffer (50 mM
Tris-HCl, pH 7.5, containing 150 mM NaCl, 10 mM CaCl2, 0.02%
Brij, and 0.02% sodium azide). Each treatment was tested in
quadruplicate samples. At the end of the incubation, all samples
were microcentrifuged (8,000 g for 5 minutes) and 100 ml aliquots
of supernatant containing the solubilized degradation products were
mixed with 4 ml scintillation fluid and counted in triplicate in liquid
scintillation counter. The radioactivity (c.p.m./sample) released into
the supernatant reflecting the degradation of [3H]elastin substrate
was assessed and the mean and standard deviations (mean7SD)
were calculated from sixtiplicate assessments from three different
experiments
Assessement of TA and EA binding to insoluble elastin
In order to directly prove that both polyphenols bind to elastin,
triplicate (1 mg) aliquots of our above-mentioned preparation of pure
insoluble elastin were incubated with 20 mg/ml of TA or EA for
2 hours at 371C. The initial concentration of both polyphenols was
confirmed by a direct spectrophotometric reading at 280 nm. This
method adopted from Gori et al. (2005) demonstrated a dose-
dependent linear increase in absorbancy. At the end of the
incubation period, the insoluble elastin slurries were separated by
centrifugation and the concentrations of polyphenols in supernatants
were determined again. The detected differences between the initial
and final concentration of polyphenols in supernatants from
particular samples directly indicated that both TA and EA bound to
elastin slurries during the incubation period. In each experimental
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group, means7SD were calculated and values obtained were stati-
stically compared with initial concentrations of both polyphenols.
Statistical analysis
In all above-mentioned quantitative assays, mean7SD were
calculated and statistical analyses were carried out by analysis of
variance (ANOVA) to establish whether detected differences were
statistically significant.
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